Diabetes News and Research

Latest Diabetes News and Research

UChicago Medicine and Advocate Health Care wins NIH grant to find new ways to prevent type 1 diabetes

The University of Chicago Medicine and Advocate Children's Hospital / Advocate Health Care have received a five-year, $1.8-million grant from the National Institutes of Health to find new ways to delay and prevent type 1 diabetes. The grant will establish the first Type 1 Diabetes TrialNet Clinical Center in Chicago.

12 Aug 2014

Research: New ways to help visually impaired better navigate everyday life

Visual impairment comes in many forms, and it's on the rise in America. A University of Cincinnati experiment aimed at this diverse and growing population could spark development of advanced tools to help all the aging baby boomers, injured veterans, diabetics and white-cane-wielding pedestrians navigate the blurred edges of everyday life.

12 Aug 2014

Researchers discover highly virulent, multidrug resistant form of pathogen in Ohio

A team of clinician researchers has discovered a highly virulent, multidrug resistant form of the pathogen, Pseudomonas aeruginosa, in patient samples in Ohio.

12 Aug 2014

Research sheds light on role of hepatic mTORC1 in whole body physiology

The protein mTOR is a central controller of growth and metabolism. Deregulation of mTOR signaling increases the risk of developing metabolic diseases such as diabetes, obesity and cancer.

12 Aug 2014

Halozyme reports revenues of $18.4 million, net loss of $16.3 million for Q2 2014

Halozyme Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2014. Financial highlights for the second quarter include revenues of $18.4 million and a net loss of $16.3 million, or $0.13 per share.

12 Aug 2014

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.

11 Aug 2014

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

Regeneron Pharmaceuticals, Inc. today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema.

11 Aug 2014

BCBSIL awards grants to improve health and wellness of the people of Illinois

Blue Cross and Blue Shield of Illinois is awarding $3,380,000 to nonprofit health and human service organizations that are making meaningful differences in the lives of the people of Illinois.

8 Aug 2014

Researchers awarded $3.3 million NIH grant to study role of genetics in protecting against frailty

Frailty is a common condition associated with old age, characterized by weight loss, weakness, decreased activity level and reduced mobility, which together increase the risk of injury and death. Yet, not all elderly people become frail; some remain vigorous and robust well into old-age.

8 Aug 2014

Inadequate management common in young-onset Type 2 diabetes

Patients with young-onset Type 2 diabetes have worse metabolic control than those with late-onset disease, but they are less likely to receive organ-protective drugs, show data from the Joint Asia Diabetes Evaluation cohort.

8 Aug 2014

Individuals with work related stress are at higher risk of developing type 2 diabetes

Workplace stress can have a range of adverse effects on health with an increased risk of cardio-vascular diseases in the first line.

8 Aug 2014

Patients treated with drug for type 2 diabetes can live longer than people without the condition

Patients treated with a drug widely prescribed for type 2 diabetes can live longer than people without the condition, a large-scale study involving over 180,000 people has shown.

8 Aug 2014

Diabetes education reduces blood sugar, blood pressure and cholesterol levels

Diabetes education significantly improves outcomes among people with the condition, leading to reduced blood sugar, blood pressure and cholesterol levels, according to data presented by the Diabetes Self-Management Education Program from New York-Presbyterian Hospital today at AADE14, the American Association of Diabetes Educators Annual Meeting & Exhibition.

8 Aug 2014

Notch signaling also plays important role in onset of obesity and Type 2 diabetes

A Purdue University study shows that Notch signaling, a key biological pathway tied to development and cell communication, also plays an important role in the onset of obesity and Type 2 diabetes, a discovery that offers new targets for treatment.

8 Aug 2014

New method of growing human cells may help develop tailor-made therapies for GI conditions

A method of growing human cells from tissue removed from a patient's gastrointestinal (GI) tract eventually may help scientists develop tailor-made therapies for inflammatory bowel disease and other GI conditions.

8 Aug 2014

People diagnosed with MCI are more likely to increase risk of developing dementia

In a long-term, large-scale population-based study of individuals aged 55 years or older in the general population researchers found that those diagnosed with mild cognitive impairment (MCI) had a four-fold increased risk of developing dementia or Alzheimer's disease (AD) compared to cognitively healthy individuals.

7 Aug 2014

First MinuteClinic walk-in medical clinics in Nebraska

The first MinuteClinic walk-in medical clinics in Nebraska are opening this week inside select CVS/pharmacy stores. Two clinics opened yesterday in Lincoln and one is opening today in Omaha. A third clinic in Lincoln and three more clinics in the Omaha area will open later this month.

7 Aug 2014

Induced immunorejection may eliminate tumors post-cell transplantation

Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation.

7 Aug 2014

Altering the circadian rhythm: an interview with Dr. Doug Kojetin, The Scripps Research Institute

The circadian rhythm is affected by many different stimuli—such as sleep and light, which are the most broadly appreciated ways—but also eating— all of which can modulate, or change, important processes in our bodies such as temperature, production of hormones or other signalling small molecules, cellular regeneration, and others.

6 Aug 2014

BD Medical announces retail pharmacy launch of BD AutoShield Duo

BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the retail pharmacy launch of BD AutoShield Duo, the only pen needle with patented dual front and back-end shields that provides greater convenience and safety before and after injecting.

From BD (Becton, Dickinson and Company) 6 Aug 2014

Diabetes News and Research

Latest Diabetes News and Research

UChicago Medicine and Advocate Health Care wins NIH grant to find new ways to prevent type 1 diabetes

Research: New ways to help visually impaired better navigate everyday life

Researchers discover highly virulent, multidrug resistant form of pathogen in Ohio

Research sheds light on role of hepatic mTORC1 in whole body physiology

Halozyme reports revenues of $18.4 million, net loss of $16.3 million for Q2 2014

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

European Commission approves EYLEA Injection for treatment of visual impairment due to DME

BCBSIL awards grants to improve health and wellness of the people of Illinois

Researchers awarded $3.3 million NIH grant to study role of genetics in protecting against frailty

Inadequate management common in young-onset Type 2 diabetes

Individuals with work related stress are at higher risk of developing type 2 diabetes

Patients treated with drug for type 2 diabetes can live longer than people without the condition

Diabetes education reduces blood sugar, blood pressure and cholesterol levels

Notch signaling also plays important role in onset of obesity and Type 2 diabetes

New method of growing human cells may help develop tailor-made therapies for GI conditions

People diagnosed with MCI are more likely to increase risk of developing dementia

First MinuteClinic walk-in medical clinics in Nebraska

Induced immunorejection may eliminate tumors post-cell transplantation

Altering the circadian rhythm: an interview with Dr. Doug Kojetin, The Scripps Research Institute

BD Medical announces retail pharmacy launch of BD AutoShield Duo

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in